£91.42

Springer Poor Quality Pharmaceuticals in Global Public Health: 5 (Trust, 5)

Price data last checked 52 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

About as cheap as it gets. The only time it was cheaper was 3 months ago.

£91 today · all-time low £91 (Apr 2026) · usually the usual

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 39 days · 39 data points (no recent data)

Historical
Generating forecast…
£91.44 £91.37 £91.39 £91.40 £91.42 £91.43 £91.45 23 April 2026 02 May 2026 12 May 2026 21 May 2026 31 May 2026

Price Distribution

Price distribution over 39 days • 1 price levels

Days at Price
39 days 0 10 20 29 39 £91 Days at Price

Price Analysis

Most common price: £91 (39 days, 100.0%)

Price range: £91 - £91

Price levels: 1 different prices over 39 days

Description

This book aims to clarify the global aspects of poor quality pharmaceuticals, generic products in particular, becoming complicated through the process of IMPACT (International Medical Products Anti-Counterfeiting Taskforce) organized by the initiative of the World Health Organization (WHO) in 2006. The findings from this book provide a long-term perspective to policymakers. This book discusses from the following points: industrial standardization, healthcare market accessibility, motivation on supply side, WHO medicines policy and intellectual property rights. Standardization regulates the quality and enabled the generic medicines spreading to developing/emerging countries through technology transfer. However, quality is a part of cost and reflected to price. When a healthcare service market is divided according to wealth gap, compliance to standardization for quality on supply side is divided accordingly. Thus, poor quality pharmaceuticals are prevalent worldwide. Generic pharmaceuticals are essential resources in public health. The WHO has been involved in the dispute around the intellectual property rights under its intention to promote the new drug development for neglected diseases. Global pandemic of AIDs is a critical factor to accelerate the confusion. This created feelings of distrust among developing/emerging countries against developed countries if the WHO was in favour of developed countries. In addition to that, an easy and optimistic start of IMPACT stirred up conflicts of interests in the international community. The problem of poor quality pharmaceuticals became more complicated through the conflicts on intellectual property rights; patented drugs to generic drugs. A key for quality generic products is the formation of a single healthcare service market where good motivation on supply side together with fair competitiveness with patented pharmaceuticals and equitable access to services (both for the rich and the poor) are ensured. Political commitment to investment and regulatory infrastructure for the market is crucial.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
17 January 2021
Listed Since
22 December 2020

Barcode

No barcode data available

Similar Products You Might Like

Patenting of Pharmaceuticals and Development in Sub-Saharan Africa: Laws, Institutions, Practices, and Politics
81% match

Patenting of Pharmaceuticals and Development in Sub-Saharan Africa: Laws, Institutions, Practices, and Politics

Springer

£76.38 05 Jun 2026
Unsettled International Intellectual Property Issues
80% match

Unsettled International Intellectual Property Issues

Kluwer Law International

£152.00 14 Jul 2026
Illicit Medicines in the Global South: Public Health Access and Pharmaceutical Regulation (Routledge Global Health Series)
80% match

Illicit Medicines in the Global South: Public Health Access and Pharmaceutical Regulation (Routledge Global Health Series)

Routledge

£41.57 01 Jun 2026
Intellectual Property, Medicine and Health (Intellectual Property, Theory, Culture)
79% match

Intellectual Property, Medicine and Health (Intellectual Property, Theory, Culture)

Routledge

£43.90 05 Jun 2026
Evaluating International Public Health Issues: Critical Reflections on Diseases and Disasters, Policies and Practices
79% match

Evaluating International Public Health Issues: Critical Reflections on Diseases and Disasters, Policies and Practices

Springer

£103.11 01 Jun 2026
Global Issues in Pharmaceutical Marketing
78% match

Global Issues in Pharmaceutical Marketing

Routledge

£55.99 24 May 2026
Global Pharmaceutical Policy
78% match

Global Pharmaceutical Policy

MACMILLAN

£106.27 25 May 2026
Public-Private Partnerships in Health: Improving Infrastructure and Technology
78% match

Public-Private Partnerships in Health: Improving Infrastructure and Technology

Springer

£38.63 27 May 2026
Intellectual Property in the Global Trading System: EU-China Perspective
78% match

Intellectual Property in the Global Trading System: EU-China Perspective

Springer

£75.32 12 Jun 2026
Global Governance of Intellectual Property in the 21st Century: Reflecting Policy Through Change
77% match

Global Governance of Intellectual Property in the 21st Century: Reflecting Policy Through Change

Springer

£89.63 14 Jun 2026
Standard-Setting Organisations’ IPR Policies: Intellectual Property and Competition Issues
77% match

Standard-Setting Organisations’ IPR Policies: Intellectual Property and Competition Issues

Springer

£95.72 21 May 2026
Intellectual Property: Global Perspective Advances and Challenges
77% match

Intellectual Property: Global Perspective Advances and Challenges

IntechOpen

£119.00 26 May 2026
Regulation, Innovation and Competition in Pharmaceutical Markets: A Comparative Study (Hart Studies in Law and Health)
77% match

Regulation, Innovation and Competition in Pharmaceutical Markets: A Comparative Study (Hart Studies in Law and Health)

Hart Publishing

£76.39 14 Jul 2026
EU Bilateral Trade Agreements and Intellectual Property: For Better or Worse?: 20 (MPI Studies on Intellectual Property and Competition Law, 20)
77% match

EU Bilateral Trade Agreements and Intellectual Property: For Better or Worse?: 20 (MPI Studies on Intellectual Property and Competition Law, 20)

Springer

£107.98 25 May 2026
Approaching China's Pharmaceutical Market: A Fundamental Guide to Clinical Drug Development
77% match

Approaching China's Pharmaceutical Market: A Fundamental Guide to Clinical Drug Development

Springer

£108.92 27 May 2026
Generic Drugs: The Pay-for-Delay Problem (Public Health in the 21st Century Series)
77% match

Generic Drugs: The Pay-for-Delay Problem (Public Health in the 21st Century Series)

£20.94 01 Jun 2026
Ethics and the Pharmaceutical Industry
77% match

Ethics and the Pharmaceutical Industry

Cambridge University Press

£39.68 09 Jun 2026
Drug Discovery in Africa: Impacts of Genomics, Natural Products, Traditional Medicines, Insights into Medicinal Chemistry, and Technology Platforms in Pursuit of New Drugs
77% match

Drug Discovery in Africa: Impacts of Genomics, Natural Products, Traditional Medicines, Insights into Medicinal Chemistry, and Technology Platforms in Pursuit of New Drugs

Springer

£107.98 05 Jun 2026
The Economics of Counterfeit Trade: Governments, Consumers, Pirates and Intellectual Property Rights
77% match

The Economics of Counterfeit Trade: Governments, Consumers, Pirates and Intellectual Property Rights

Springer

£76.38 11 May 2026
India and the Patent Wars: Pharmaceuticals in the New Intellectual Property Regime (The Culture and Politics of Health Care Work)
77% match

India and the Patent Wars: Pharmaceuticals in the New Intellectual Property Regime (The Culture and Politics of Health Care Work)

Cornell University Press

£85.65 29 May 2026
A Textbook of Pharmaceutical Quality Assurance
77% match

A Textbook of Pharmaceutical Quality Assurance

PharmaMed Press

£42.70 14 Jul 2026
Quick Guide to Good Clinical Practice: How to Meet International Quality Standard in Clinical Research
77% match

Quick Guide to Good Clinical Practice: How to Meet International Quality Standard in Clinical Research

Springer

£76.41 27 May 2026
Changing Innovation in the Pharmaceutical Industry: Globalization and New Ways of Drug Development
77% match

Changing Innovation in the Pharmaceutical Industry: Globalization and New Ways of Drug Development

Springer

£76.38 01 Jun 2026
Improving Healthcare: A Dose of Competition: 9 (Developments in Health Economics and Public Policy, 9)
76% match

Improving Healthcare: A Dose of Competition: 9 (Developments in Health Economics and Public Policy, 9)

Springer

£129.11 18 May 2026